Clinical Trial Update: Lactobacillus Reuteri DSM 17938 in the Prevention of Antibiotic-associated Diarrhea in Children: Protocol of a Randomized Controlled Trial [Phase 4]

View source ↗

Summary

This document outlines the protocol for a Phase 4 randomized controlled trial to evaluate whether Lactobacillus reuteri DSM 17938 can prevent antibiotic-associa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antibiotic-associated Diarrhea
• Diarrhea

Drugs mentioned

• Lactobacillus reuteri DSM 17938 (Lactobacillus reuteri DSM 17938)

Snippet

Sponsor: Medical University of Warsaw | Conditions: Diarrhea, Antibiotic Associated Diarrhea | Phase 4 | Status: COMPLETED